Drug Profile
Research programme: sphingosine 1 phosphate receptor agonists - Exelixis
Latest Information Update: 10 Mar 2011
Price :
$50
*
At a glance
- Originator Exelixis
- Class
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 22 Feb 2011 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 12 Dec 2008 Preclinical trials in Inflammation in USA (unspecified route)